Infratil, in partnership with MGIF, acquired a majority stake in Qscan Group from Quadrant Private Equity (QPE) and existing doctor shareholders. The transaction valued the entire group at an enterprise value of AUD 735 million. The deal was structured to provide Infratil with a platform in the high-growth diagnostic imaging market, characterized by aging demographics and the increasing clinical importance of early cancer detection. The acquisition was funded through Infratil's existing debt facilities and cash proceeds from previous divestments, reflecting a shift in their portfolio towards healthcare infrastructure.

QSCAN GROUP, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.4x average currently observed in the Healthcare & Pharma sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.